BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33549872)

  • 1. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study.
    Vajravelu RK; Kolb JM; Thanawala SU; Scott FI; Han S; Singal AG; Falk GW; Katzka DA; Wani S
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1739-1747. PubMed ID: 33549872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study.
    Wani S; Holmberg D; Santoni G; Kauppila JH; Farkkila M; von Euler-Chelpin M; Shaheen NJ; Lagergren J
    Gastroenterology; 2023 Oct; 165(4):909-919.e13. PubMed ID: 37279832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
    Sawas T; Majzoub AM; Haddad J; Tielleman T; Nayfeh T; Yadlapati R; Singh S; Kolb J; Vajravelu RK; Katzka DA; Wani S;
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e31-e50. PubMed ID: 33901662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
    Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA
    Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study.
    Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; Schipper ME; Casparie MK; van Baal JW; Siersema PD
    Am J Gastroenterol; 2012 Apr; 107(4):534-42. PubMed ID: 22270082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
    Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P
    Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus.
    El-Serag HB; Naik AD; Duan Z; Shakhatreh M; Helm A; Pathak A; Hinojosa-Lindsey M; Hou J; Nguyen T; Chen J; Kramer JR
    Gut; 2016 Aug; 65(8):1252-60. PubMed ID: 26311716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis.
    Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
    Gastroenterology; 2016 Mar; 150(3):599-607.e7; quiz e14-5. PubMed ID: 26619962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
    Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women.
    Allen JE; Desai M; Roumans CAM; Vennalaganti S; Vennalaganti P; Bansal A; Falk G; Lieberman D; Sampliner R; Thota P; Vargo J; Gupta N; Moawad F; Bruno M; Kennedy KF; Gaddam S; Young P; Mathur S; Cash B; Spaander M; Sharma P
    J Clin Gastroenterol; 2021 Apr; 55(4):321-326. PubMed ID: 32379085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
    Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P
    Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
    Hammad TA; Thrift AP; El-Serag HB; Husain NS
    Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan.
    Matsuhashi N; Sakai E; Ohata K; Ishimura N; Fujisaki J; Shimizu T; Iijima K; Koike T; Endo T; Kikuchi T; Inayoshi T; Amano Y; Furuta T; Haruma K; Kinoshita Y
    J Gastroenterol Hepatol; 2017 Feb; 32(2):409-414. PubMed ID: 27416773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-endoscopy Barrett's neoplasia after a negative index endoscopy: a systematic review and proposal for definitions and performance measures in endoscopy.
    Desai M; Lieberman D; Srinivasan S; Nutalapati V; Challa A; Kalgotra P; Sundaram S; Repici A; Hassan C; Kaminski MF; Sharma P
    Endoscopy; 2022 Sep; 54(9):881-889. PubMed ID: 34979570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening and surveillance of Barrett's esophagus.
    Michalak J; Bansal A; Sharma P
    Curr Gastroenterol Rep; 2009 Jun; 11(3):195-201. PubMed ID: 19463219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receipt of Serial Endoscopy Procedures Prior to Esophageal Adenocarcinoma Diagnosis Is Associated with Better Survival.
    Cummings LC; Kou TD; Chak A; Schluchter MD; Margevicius S; Cooper GS
    Dig Dis Sci; 2022 Mar; 67(3):1036-1044. PubMed ID: 33881677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus.
    Thota PN; Kistangari G; Singh P; Cummings L; Hajifathalian K; Lopez R; Sanaka MR
    Dig Dis Sci; 2016 Jan; 61(1):247-54. PubMed ID: 26233550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.